Get startedLog in
    Picture of Tiziana Life Sciences logo

    TLSA — Tiziana Life Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapNeutral
    All News

    Brief: Tiziana Life Sciences Announces Grant Received By The Brigham And Women’S Hospital To Explore The Use Of Intranasal Anti-Cd3 Mab In Amyotrophic Lateral Sclerosis

    Picture of Tiziana Life Sciences logoTiziana Life Sciences
    15/09/2022 12:13
    Sept 15 (Reuters) - Tiziana Life Sciences Ltd  TLSA.O :
    * TIZIANA LIFE SCIENCES ANNOUNCES GRANT RECEIVED BY THE
BRIGHAM
AND WOMEN’S HOSPITAL TO EXPLORE THE USE OF INTRANASAL ANTI-CD3
MAB IN AMYOTROPHIC LATERAL SCLEROSIS

Source text for Eikon:  ID:nGNX2q6SJn 
Further company coverage:  TLSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Tiziana Life Sciences

    See all news